Clinical Trial: Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML

U.S., Feb. 15 -- ClinicalTrials.gov registry received information related to the study (NCT06827899) titled 'Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML' on Feb. 11.

Brief Summary: A multicenter, prospective, single-arm clinical study of veneclax, chidaniline combined with azacitidine (VCA) followed by decitabine + MAG regimen (D-MAG) in the treatment of elderly untreated acute myeloid leukemia (AML)

Study Start Date: July 01, 2022

Study Type: INTERVENTIONAL

Condition: Acute Myeloid Leukemia

Intervention: DRUG: veneclax, chidaniline combined with azacitidine (VCA) followed by decitabine + MAG regimen (D-MAG)

Specified dose on specified days

Recruitme...